Are you ready to elevate your biologics expertise and stay ahead of industry trends?

Leaders from Mycenax’s Drug Development Division have been invited to speak in an upcoming professional online course, where they will share practical insights and industry perspectives on the rapidly evolving field of biopharmaceuticals.

This course will help participants understand the global trends shaping the CDMO landscape, explore the core technologies behind Antibody-Drug Conjugates (ADC), and discover the latest breakthroughs in regenerative medicine. Attendees will also gain foundational knowledge in cell culture, bioreactor operations, and Chemistry, Manufacturing, and Controls (CMC) in biologics manufacturing.

Featured Speakers & Topics:

Wei-I Chou, Pharmaceutical Development Associate Vice President

• Emerging Trends in Biopharmaceuticals and the CDMO Industry
• Core Technologies in ADC Drug Development

Peggy Tseng, Pharmaceutical Development Senior Manager

• New Breakthroughs in Regenerative Medicine

Jih-Huong Guo, Pharmaceutical Development Manager

• Introduction to Cell Culture and Bioreactor Applications

Hui-Ju (Judy) Yang, Pharmaceutical Development Associate Manager

• Fundamentals of Chemistry, Manufacturing, and Controls (CMC) in Biologics

Whether you're looking to broaden your technical knowledge or better understand the skills needed in today’s biotech industry, this course offers valuable learning and perspective.

• Course Duration: 6 hours
•  Format: Online
• Registration link: https://reurl.cc/mxa6RV